Seizert Capital Partners’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-40,543
Closed -$539K 201
2022
Q3
$539K Buy
40,543
+10,866
+37% +$188K 0.03% 149
2022
Q2
$568K Buy
29,677
+10,607
+56% +$201K 0.03% 162
2022
Q1
$380K Hold
19,070
0.02% 175
2021
Q4
$389K Buy
+19,070
New +$407K 0.02% 183
2019
Q3
Sell
-30,668
Closed -$974K 218
2019
Q2
$974K Sell
30,668
-1,345
-4% -$42.2K 0.05% 133
2019
Q1
$1.06M Sell
32,013
-189
-0.6% -$5.88K 0.05% 134
2018
Q4
$1.04M Sell
32,202
-217
-0.7% -$8.19K 0.05% 129
2018
Q3
$1.39M Sell
32,419
-14,105
-30% -$666K 0.05% 128
2018
Q2
$1.85M Hold
46,524
0.07% 114
2018
Q1
$1.85M Sell
46,524
-287
-0.6% -$10.6K 0.07% 114
2017
Q4
$1.57M Sell
46,811
-1,939
-4% -$68.8K 0.06% 125
2017
Q3
$1.81M Sell
48,750
-5,837
-11% -$219K 0.07% 116
2017
Q2
$2.02M Buy
54,587
+572
+1% +$18.7K 0.07% 117
2017
Q1
$1.52M Buy
+54,015
New +$1.52M 0.05% 129

Other funds holding PAHC

Seizert Capital Partners's PAHC Position: Q4 2022 in Review

Seizert Capital Partners sold out of Phibro Animal Health (PAHC) in Q4 2022, closing a stake of 40,543 shares — an estimated $539K sold.

Seizert Capital Partners first reported a position in PAHC in Q1 2017 and held it in 14 quarters. The position peaked at $2.02M in Q2 2017. 132 funds tracked by Wall St. Rank hold PAHC as of Q4 2022.

  • Seizert Capital Partners reported no remaining Phibro Animal Health position as of Q4 2022 after selling out during the quarter.
  • Seizert Capital Partners sold 40,543 Phibro Animal Health shares in Q4 2022, an estimated $539K.
  • Seizert Capital Partners first reported a position in Phibro Animal Health in Q1 2017 and held it in 14 quarters.
  • Seizert Capital Partners's Phibro Animal Health position peaked at $2.02M in Q2 2017.
  • 132 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2022.

Based on Seizert Capital Partners's 13F filing for Q4 2022, filed 30 Jan 2023.